Article Text

Download PDFPDF
Impact of secondary prevention on survival in patients with stroke: from clinical trials to clinical practice
  1. Yannick Béjot,
  2. Maurice Giroud
  1. Dijon Stroke Registry, University of Burgundy, University Hospital and Faculty of Medicine of Dijon, France
  1. Correspondence to Dr Yannick Béjot, Dijon Stroke Registry, EA4184, Department of Neurology, University Hospital, 3 Rue du Faubourg Raines, 21000 Dijon, France; ybejot{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Over recent decades, the emergence of evidence-based medicine has largely contributed to our knowledge of vascular risk factors for stroke. Hence, there has been considerable progress in secondary prevention of stroke thanks to randomised clinical trials, which have highlighted the efficacy of several therapies in reducing the risk of stroke recurrence and mortality. This has led to the publication of guidelines for stroke management worldwide.1 2 However, the extent to which these guidelines have been applied and their impact on the outcome in patients with stroke still need to be explored on a larger scale.

A recent systematic review of population-based studies demonstrated a decline in …

View Full Text


  • Linked articles 193136

  • Provenance and peer review Not commissioned; not externally peer reviewed.

Linked Articles